| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Analysing stratified medicine business models and value systems: innovation-regulation interactions
|
Mittra, James
|
|
2012
|
29 |
6 |
p. 709-719
11 p.
|
article
|
| 2 |
A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory
|
Hood, Leroy
|
|
2012
|
29 |
6 |
p. 613-624
12 p.
|
article
|
| 3 |
Autologous stem cells for personalised medicine
|
Prasongchean, Weerapong
|
|
2012
|
29 |
6 |
p. 641-650
10 p.
|
article
|
| 4 |
Best practices for companion diagnostic and therapeutic development: translating between the stakeholders
|
Love, Delicia
|
|
2012
|
29 |
6 |
p. 689-694
6 p.
|
article
|
| 5 |
Co-development of a companion diagnostic for targeted cancer therapy
|
Cheng, Suzanne
|
|
2012
|
29 |
6 |
p. 682-688
7 p.
|
article
|
| 6 |
Do companion diagnostics make economic sense for drug developers?
|
Agarwal, Amit
|
|
2012
|
29 |
6 |
p. 695-708
14 p.
|
article
|
| 7 |
From morphologic to molecular: established and emerging molecular diagnostics for breast carcinoma
|
Portier, Bryce P.
|
|
2012
|
29 |
6 |
p. 665-681
17 p.
|
article
|
| 8 |
Molecular tools for companion diagnostics
|
Zieba, Agata
|
|
2012
|
29 |
6 |
p. 634-640
7 p.
|
article
|
| 9 |
Overcoming regulatory and economic challenges facing pharmacogenomics
|
Cohen, Joshua P.
|
|
2012
|
29 |
6 |
p. 751-756
6 p.
|
article
|
| 10 |
Personalised Medicine in 2012: Editorial to the Special Issue of New Biotechnology on “MOLECULAR DIAGNOSTICS & PERSONALISED MEDICINE”
|
Desiere, Frank
|
|
2012
|
29 |
6 |
p. 611-612
2 p.
|
article
|
| 11 |
Pharmacogenomics and personalized medicine: wicked problems, ragged edges and ethical precipices
|
Fleck, Leonard M.
|
|
2012
|
29 |
6 |
p. 757-768
12 p.
|
article
|
| 12 |
Practical perspectives of personalized healthcare in oncology
|
Hodgson, Darren R.
|
|
2012
|
29 |
6 |
p. 656-664
9 p.
|
article
|
| 13 |
Predictive markers in early research and companion diagnostic developments in oncology
|
Pickl, Marlene
|
|
2012
|
29 |
6 |
p. 651-655
5 p.
|
article
|
| 14 |
Public–private collaborations and partnerships in stratified medicine: making sense of new interactions
|
Chataway, Joanna
|
|
2012
|
29 |
6 |
p. 732-740
9 p.
|
article
|
| 15 |
The economics of personalized medicine: commercialization as a driver of return on investment
|
Keeling, Peter
|
|
2012
|
29 |
6 |
p. 720-731
12 p.
|
article
|
| 16 |
The future of technologies for personalised medicine
|
Harvey, Alison
|
|
2012
|
29 |
6 |
p. 625-633
9 p.
|
article
|
| 17 |
The triad of success in personalised medicine: pharmacogenomics, biotechnology and regulatory issues from a Central European perspective
|
Mesko, Bertalan
|
|
2012
|
29 |
6 |
p. 741-750
10 p.
|
article
|
Journal description